Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
+$985M |
| 2 |
RTX Corp
RTX
|
+$517M |
| 3 |
Bank of America
BAC
|
+$445M |
| 4 |
Comcast
CMCSA
|
+$428M |
| 5 |
Cisco
CSCO
|
+$363M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.03B |
| 2 |
Thermo Fisher Scientific
TMO
|
+$458M |
| 3 |
JD.com
JD
|
+$385M |
| 4 |
PPL Corp
PPL
|
+$376M |
| 5 |
AMC Entertainment Holdings
AMC
|
+$342M |
Sector Composition
| 1 | Technology | 19.34% |
| 2 | Consumer Discretionary | 13.34% |
| 3 | Financials | 12.95% |
| 4 | Healthcare | 11.95% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Atlanta Braves Holdings Series A
BATRA
$2.92B
| $236K | ﹤0.01% |
8,352
+607
| +8% | +$17.2K |
|
3602
eGain
EGAN
$211M
| $235K | ﹤0.01% |
20,457
+1,853
| +10% | +$21.3K |
|
|
INBX
3603
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $234K | ﹤0.01% |
+8,501
| New | +$234K |
|
3604
Aurinia Pharmaceuticals
AUPH
$1.62B
| $233K | ﹤0.01% |
+17,971
| New | +$233K |
|
|
EARN
3605
Ellington Residential Mortgage REIT
EARN
$212M
| $233K | ﹤0.01% |
19,807
-8,424
| -30% | -$99.1K |
|
3606
Privia Health
PRVA
$2.9B
| $233K | ﹤0.01% |
+5,251
| New | +$233K |
|
|
SMM
3607
DELISTED
Salient Midstream & MLP Fund
SMM
| $233K | ﹤0.01% |
39,073
+1,116
| +3% | +$6.66K |
|
3608
Reading International Class A
RDI
$35M
| $232K | ﹤0.01% |
33,252
-279
| -0.8% | -$1.95K |
|
3609
Synchronoss Technologies
SNCR
$65.2M
| $232K | ﹤0.01% |
7,175
-1,227
| -15% | -$39.7K |
|
|
CLVS
3610
DELISTED
Clovis Oncology, Inc.
CLVS
| $232K | ﹤0.01% |
40,072
+19,254
| +92% | +$111K |
|
|
LFC
3611
DELISTED
China Life Insurance Company Ltd.
LFC
| $231K | ﹤0.01% |
23,240
-82,934
| -78% | -$824K |
|
3612
Gaotu Techedu
GOTU
$877M
| $228K | ﹤0.01% |
+15,434
| New | +$228K |
|
|
NML
3613
Neuberger Berman Energy Infrastructure and Income Fund
NML
$488M
| $228K | ﹤0.01% |
45,514
-146
| -0.3% | -$731 |
|
|
PYN
3614
DELISTED
PIMCO New York Municipal Income Fund III
PYN
| $228K | ﹤0.01% |
21,230
-79
| -0.4% | -$848 |
|
3615
TIM SA
TIMB
$10.1B
| $228K | ﹤0.01% |
19,825
-8,797
| -31% | -$101K |
|
|
BTRS
3616
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $228K | ﹤0.01% |
+18,158
| New | +$228K |
|
3617
GSK
GSK
$80.6B
| $227K | ﹤0.01% |
4,561
-4,188
| -48% | -$208K |
|
3618
Alaunos Therapeutics
TCRT
$4.33M
| $227K | ﹤0.01% |
574
+230
| +67% | +$91K |
|
3619
Rush Street Interactive
RSI
$2B
| $225K | ﹤0.01% |
+18,351
| New | +$225K |
|
3620
Esperion Therapeutics
ESPR
$506M
| $225K | ﹤0.01% |
+10,630
| New | +$225K |
|
3621
Rafael Holdings
RFL
$47M
| $225K | ﹤0.01% |
+4,482
| New | +$225K |
|
3622
Boston Omaha
BOC
$425M
| $224K | ﹤0.01% |
7,074
-52,550
| -88% | -$1.66M |
|
|
YI
3623
111 Inc
YI
$49.9M
| $224K | ﹤0.01% |
2,462
-85
| -3% | -$7.73K |
|
|
XONE
3624
DELISTED
The ExOne Company
XONE
| $224K | ﹤0.01% |
10,339
-258,238
| -96% | -$5.59M |
|
|
CRON
3625
Cronos Group
CRON
$950M
| $223K | ﹤0.01% |
25,894
+15,709
| +154% | +$135K |
|